Regulatory Filings • Dec 10, 2025
Regulatory Filings
Open in ViewerOpens in native device viewer
FORM 8-K: ����� �� ����� �����, ����� ��"�, ������ ������ ������ ���� false
| ����� ���� | 2 380 |
| PLURI INC | |
| Corporation no: C12337-2001 | 8543 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 09/12/2025 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2025-02-098210 | Time of broadcast: 23:15 23:15 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onFORM 8-K: ����� �� ����� �����, ����� ��"�, ������ ������ ������ ����
Pluri_Inc_-_Form_8K_-_December_9_2025_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: NASDAQ CM | Date of revision of form structure: 06/08/2024 |
| Address: Matam Park 5 , Haifa 31905 ISRAEL , Tel: 074-7107171 , Fax: 074-7107172 | |
| E-mail address: [email protected] Company site: www.pluristem.com | |
| Previous names of reporting entity: PLURISTEM THERAPEUTICS INC | |
| Name of the Signatory: Yanay Yaacov Position of Signatory in the reporting corporation: CEO and Director Name of Employer Company: | |
| Address: Matam Park 5 , Haifa 3508409 Telephone: 074-7107171 Facsimile: 074-7107172 E-mail: [email protected] 1 | |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.